Comment on: GLP-1 receptor agonists and male sexual health: translating cardiometabolic benefits into erectile outcomes

Harrison Smith, Brantley Nelson, Taylor Kohn

Open source

DOI
10.1038/s41443-026-01337-1
Published
2026-09-04
Container
International Journal of Impotence Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41443-026-01337-1,
  title = {Comment on: GLP-1 receptor agonists and male sexual health: translating cardiometabolic benefits into erectile outcomes},
  author = {Harrison Smith and Brantley Nelson and Taylor Kohn},
  year = {2026},
  journal = {International Journal of Impotence Research},
  doi = {10.1038/s41443-026-01337-1},
  url = {https://doi.org/10.1038/s41443-026-01337-1}
}

RIS

TY  - JOUR
TI  - Comment on: GLP-1 receptor agonists and male sexual health: translating cardiometabolic benefits into erectile outcomes
AU  - Harrison Smith
AU  - Brantley Nelson
AU  - Taylor Kohn
PY  - 2026
JO  - International Journal of Impotence Research
DO  - 10.1038/s41443-026-01337-1
UR  - https://doi.org/10.1038/s41443-026-01337-1
ER  - 

APA

Smith, H., Nelson, B., & Kohn, T. (2026). Comment on: GLP-1 receptor agonists and male sexual health: translating cardiometabolic benefits into erectile outcomes. International Journal of Impotence Research. https://doi.org/10.1038/s41443-026-01337-1

Source records